Molecular Dynamics-Assisted Discovery of Novel Phosphodiesterase-5 Inhibitors Targeting a Unique Allosteric Pocket
Molecules · 2025
DOI: 10.3390/molecules30030588 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Weihao Luo und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Guangdong Pharmaceutical University, Zhongshan 528458, China. Hauptthemen laut MEDLINE: Phosphodiesterase 5 Inhibitors, Molecular Dynamics Simulation, Cyclic Nucleotide Phosphodiesterases, Type 5, Drug Discovery. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Natural Science Foundation of China.
Abstract (Originalsprache)
Phosphodiesterase-5 (PDE5) is a potent therapeutic target for the treatment of male erectile dysfunction and pulmonary arterial hypertension with several drugs available on the market. However, most of the reported PDE5 inhibitors lack specificity over PDE6, a holoenzyme in eleven PDE families, which may cause various adverse effects. Targeting a unique allosteric pocket has proved to be an effective approach to designing selective PDE5 inhibitors. In the present study, an integrated virtual screening procedure consisting of pharmacophore modeling screening, molecular docking, molecular dynamics simulations, and binding free energy calculations was applied to the discovery of novel PDE5 inhibitors targeting the allosteric pocket. Seven out of thirty-three molecules purchased from the SPECS database (a hitting accuracy of 21%) with novel scaffolds were PDE5 inhibitors with enzymatic inhibition ratios of more than 50% at a concentration of 10 μM. Predicted binding patterns indicate these hits fit well in the allosteric pocket in PDE5. In particular, compound AI-898/12177002 (IC50 = 1.6 μM) demonstrates over 10-fold selectivity towards PDE6, providing a novel scaffold for the optimization of potent and selective PDE5 inhibitors with less adverse effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Chemical Engineering, Guangdong Pharmaceutical University, Zhongshan 528458, China.
- School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
- Key Laboratory of Tropical Biological Resources of Ministry of Education, Hainan Engineering Research Center for Drug Screening and Evaluation, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China.
ORCID-Profile: Runduo Liu, Qian Zhou, Chen Zhang
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Natural Science Foundation of China
Zitieren
APA
Luo, W., Liu, R., Cai, X., Zhou, Q., & Zhang, C. (2025). Molecular Dynamics-Assisted Discovery of Novel Phosphodiesterase-5 Inhibitors Targeting a Unique Allosteric Pocket. Molecules. https://doi.org/10.3390/molecules30030588
Vancouver
Luo W, Liu R, Cai X, Zhou Q, Zhang C. Molecular Dynamics-Assisted Discovery of Novel Phosphodiesterase-5 Inhibitors Targeting a Unique Allosteric Pocket. Molecules. 2025. doi:10.3390/molecules30030588
BibTeX
@article{Luo2025,
author = {Luo, Weihao and Liu, Runduo and Cai, Xinlin and Zhou, Qian and Zhang, Chen},
title = {Molecular Dynamics-Assisted Discovery of Novel Phosphodiesterase-5 Inhibitors Targeting a Unique Allosteric Pocket},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30030588}
}
EUVIMED